• 06/10/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of May 31, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of May 31, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250610_PR_shares_votingrights_May2025.pdf
  • 05/28/2025, Sophia Antipolis, France

    Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 17, 2025

    Press release – For immediate release – 5:45 pm CEST Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 17, 2025 The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) are invited to participate in the Shareholders’ Ordinary and Extraordinary General […]
    Read more Download 20250528_PR_OEGM_17June2025_EN.pdf
  • 05/27/2025, Sophia Antipolis, France

    Median Technologies to showcase iCRO’s central and AI-powered imaging services for oncology clinical trials at ASCO 2025

    Median Technologies announced today that the Company will be participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 30 to June 2, McCormick Place, Chicago, IL, USA. Median’s team will be hosting interested parties at booth #11046, South Building, Hall A, from May 31 to June 2 (exhibit dates), 9:00 am – 5:00 pm CT, where it will share the most recent advances for its central and AI-powered imaging services for oncology clinical trials.
    Read more Download 20250527_PR_ASCO2025_EN_final.pdf
  • 05/16/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of April 30, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of April 30, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250516_PR_shares_votingrights_April2025.pdf
  • 05/14/2025, Sophia Antipolis, France

    Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS

    Submission is based on positive data from two pivotal studies, REALITY and RELIVE, which both met their primary endpoints.U.S. clearance is expected in Q3 2025 based on average observed review timelines for radiological medical devices.
    Read more Download 20250514_PR_FDA-Filing_EN.pdf
  • 05/12/2025, Sophia Antipolis, France

    Median Technologies to present scientific posters on eyonis® LCS in two major health conferences in North America in May 2025

    Press release – For immediate release – 5:45 pm CEST Median Technologies to present scientific posters on eyonis® LCS in two major health conferences in North America in May 2025 Projected economic benefits of using AI-powered detection/ diagnostic Software as a Medical Device, like eyonis® LCS, will be presented at ISPOR 2025, the annual conference of […]
    Read more Download 20250508_PR_ISPORATS_Conferences_EN_final.pdf
  • 05/06/2025,

    Median Technologies to participate in several investor conferences in May and June 2025

    Median Technologies announced today that the Company will participate in upcoming investor conferences in May and June 2025. Please get in touch through the respective conference booking systems, if you would like to request a one-on-one meeting with Median management at these events. Conferences are for institutional investors only.
    Read more Download 20250505_PR_Investorconference_H12025.pdf
  • 04/29/2025, Sophia Antipolis, France

    Median Technologies reports full-year 2024 financial results

    Median Technologies today reported its 2024 consolidated annual financial results, as of December 31, 2024. The consolidated financial statements for the financial year ended December 31, 2024, were audited and approved by the Company’s Board of Directors on April 28, 2025.
    Read more Download 20250429_PR_FY2024_EN_final.pdf
  • 04/24/2025, Sophia Antipolis, France

    Median Technologies reports 2025 Q1 key financial indicators and provides an update on Q1 key operational achievements

    Median Technologies releases today its Q1 2025 key financial indicators (unaudited) and provides an update on Q1 operational achievements.
    Read more Download 20250424_PR_Q12025_EN_final.pdf
  • 04/07/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of March 31, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of March 31, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250407_PR_shares_votingrights_March2025.pdf
    • 1 … 42